Cell Based Therapy for Type 1 Diabetes: Should We Take Hyperglycemia Into Account?

by Anna Grohová, Anna Grohová, Anna Grohová, Klára Dáňová, Klára Dáňová, Radek Špíšek, Radek Špíšek, Lenka Palová-Jelínková, Lenka Palová-Jelínková
Published 2019-02-01

Myeloid - derived suppressor cells in Type 1 diabetes are an expanded population exhibiting diverse T-cell suppressor mechanisms.

by Anna Grohová, Klára Dáňová, Irena Adkins, Zdeněk Šumník, Lenka Petruželková, Barbora Obermannová, Stanislava Koloušková, Radek Špíšek, Lenka Palová-Jelínková
Published 2020-01-01

Myeloid - derived suppressor cells in Type 1 diabetes are an expanded population exhibiting diverse T-cell suppressor mechanisms

by Anna Grohová, Klára Dáňová, Irena Adkins, Zdeněk Šumník, Lenka Petruželková, Barbora Obermannová, Stanislava Koloušková, Radek Špíšek, Lenka Palová-Jelínková, Veena Taneja
Published 2020-01-01